Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 17, Issue 16, Pages 5998
Publisher
MDPI AG
Online
2020-08-18
DOI
10.3390/ijerph17165998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant denosumab in early breast-cancer
- (2020) Paul de Boissieu et al. LANCET ONCOLOGY
- Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents
- (2020) Ourania Nicolatou‐Galitis et al. ORAL DISEASES
- Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review
- (2019) M.F. Escobedo et al. Journal of Stomatology Oral and Maxillofacial Surgery
- Workshop of European Task Force on Medication Related Osteonecrosis of the Jaw.Current challenges
- (2019) Morten Schiodt et al. ORAL DISEASES
- Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study
- (2019) Ana Laura Soares et al. SUPPORTIVE CARE IN CANCER
- OSTEOPOROTIC FRACTURES DURING BISPHOSPHONATE DRUG HOLIDAY
- (2018) Brittany Bindon et al. Endocrine Practice
- Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study
- (2018) Annette L Adams et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronic Acid Induces Site-Specific Structural Changes and Decreases Vascular Area in the Alveolar Bone
- (2018) Mariana Quirino Silveira Soares et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
- (2018) Noopur Raje et al. LANCET ONCOLOGY
- Imaging of Radiation- and Medication-Related Osteonecrosis
- (2018) Sanjay M. Mallya et al. RADIOLOGIC CLINICS OF NORTH AMERICA
- Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
- (2018) Tomoko Higuchi et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
- (2018) Olga Di Fede et al. Biomed Research International
- Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
- (2018) Ourania Nicolatou-Galitis et al. SUPPORTIVE CARE IN CANCER
- Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment
- (2018) Ourania Nicolatou-Galitis et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review
- (2017) Paul de Boissieu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
- (2017) Panagiotis Anagnostis et al. MATURITAS
- Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study
- (2017) PPL Fung et al. ORAL DISEASES
- Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
- (2017) Si-yong Gao et al. PLoS One
- A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors
- (2017) M Manfredi et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis
- (2017) Gayathri Subramanian et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
- (2016) Vittorio Fusco et al. Expert Opinion On Drug Safety
- Medication-Related Osteonecrosis of the Jaw Around Dental Implants
- (2016) Ilaria Giovannacci et al. JOURNAL OF CRANIOFACIAL SURGERY
- Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis
- (2016) J Bagan et al. ORAL DISEASES
- Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review
- (2016) CC de Oliveira et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed
- (2015) Stefano Fedele et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Drug induced osteonecrosis of the jaw
- (2015) Issam S. Hamadeh et al. CANCER TREATMENT REVIEWS
- Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease
- (2014) Alberto Bedogni et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents
- (2014) Giuseppina Campisi et al. Future Oncology
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
- (2014) Salvatore L. Ruggiero et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis
- (2014) John W. Hellstein et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database
- (2014) Paul de Boissieu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
- (2012) Michael McClung et al. AMERICAN JOURNAL OF MEDICINE
- The relationship of denosumab pharmacology and osteonecrosis of the jaws
- (2012) John Malan et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study
- (2011) Paolo Vescovi et al. ORAL ONCOLOGY
- Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series
- (2010) Stefano Fedele et al. AMERICAN JOURNAL OF MEDICINE
- Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro
- (2009) Thomas Ziebart et al. Clinical Oral Investigations
- Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Initial Discovery and Subsequent Development
- (2009) Salvatore L. Ruggiero JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- American Association of Oral and Maxillofacial Surgeons Position Paper: Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update: The Need to Refine the BRONJ Definition
- (2009) Giuseppe Colella et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology
- (2008) Alberto Bedogni et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started